中文产业新闻精选评分71Chinese source
诺华镥[177Lu]特昔维匹肽获NMPA批准，用于PSMA阳性转移性激素敏感性前列腺癌一线治疗
刚刚！派威妥®获批mHSPC适应症，镥[¹⁷⁷Lu]特昔维匹肽进入国内转移性前列腺癌一线治疗
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
刚刚！派威妥®获批mHSPC适应症，镥[¹⁷⁷Lu]特昔维匹肽进入国内转移性前列腺癌一线治疗
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.